Updated and contextualized version of an article originally published on July 29, 2020
The article retains its original focus by presenting it through a scholarly and accessible perspective, supported by verifiable references.
Authors
- Dr. M. Mondini – Biologist
- Roberto Panzironi –Independent researcher
Note editoriali
- First publication: July 29, 2020
- Last update: April 18, 2026
- Version: 2026 narrative revision
Editorial Note
This article was previously published and has been updated to align with current scientific evidence and popular science communication criteria. The text is for informational purposes only and does not replace medical or professional advice. For therapeutic or nutritional choices, consult a qualified healthcare professional.
IN BRIEF
- Amino acids, especially essential amino acids and leucine, are the building blocks of protein synthesis and play a central role in muscle repair and growth.
- Experimental evidence shows clear biological mechanisms (mTOR signaling, stimulation of protein translation), but the practical effectiveness of BCAA supplementation alone is variable.
- In older adults and in conditions of insufficient protein intake, targeted supplementation (e.g., leucine or essential amino acids) can contribute to the preservation of muscle mass and function.
- For performance, amino acids can help reduce the perception of central fatigue in some situations; however, benefits on strength and mass depend on diet, training, and dosage.
- Observational literature highlights associations between circulating BCAA levels and metabolic risk: interpret with caution and distinguish association from causality.
Abstract: what does science say?
Introductory summary: amino acids are essential components of proteins. In recent decades, research has clarified several mechanisms by which specific amino acids (particularly leucine) stimulate muscle protein synthesis. However, the translation of these mechanisms into clinical or performance benefits depends on many variables: total protein quantity in the diet, timing of intake, presence of resistance training, and physiological state (e.g., elderly, malnourished). Experimental evidence (cellular models and acute studies) is solid for the mechanisms; clinical evidence on the long-term effectiveness of isolated supplementation is more heterogeneous. Interpreting the results requires caution: much research is observational or short-term and does not support absolute conclusions.
Simple definition
Amino acids are the units that make up proteins. Essential amino acids cannot be produced by the body and must be introduced through diet. Among these, leucine is recognized as one of the main activators of pathways that promote protein synthesis in muscle. The set of essential amino acids provides the necessary substrate for building new fibers and for repair after training stress.
What available evidence shows
Laboratory studies and acute interventions in people show that increasing the plasma concentration of essential amino acids, and particularly leucine, activates intracellular signals (e.g., mTOR) that promote the translation of muscle proteins. However, the translation of these effects into improved long-term muscle mass and function varies depending on the nutritional context and physical activity of the subject.
What depends on dose, frequency, and context
The effect of amino acids is not just a matter of presence/absence: the absolute daily protein dose, its distribution throughout the day, the presence of resistance exercise, and the state of health (age, malnutrition, chronic diseases) all matter. The form (whole proteins vs. free amino acid mix) also influences absorption and biological effects.
Interpretive limitations
Many publications show associations between plasma levels of certain amino acids and metabolic diseases: however, observational studies can be confounded by dietary and metabolic factors. Randomized clinical interventions offer more robust evidence, but the quality and duration of studies are variable. For this reason, universal recommendations cannot be drawn based on a few short-term studies.
What it means in practice
In practical terms, amino acids and proteins deserve attention as part of an overall strategy for muscle health and performance. From a mechanistic point of view, essential amino acids and, in particular, leucine, stimulate intracellular pathways that increase protein synthesis and promote muscle anabolism [1]. This effect is more evident when accompanied by resistance exercises and adequate protein intake throughout the day [2].
In older adults with reduced muscle mass (sarcopenia), some clinical studies suggest benefits when supplementing with leucine or formulas rich in essential amino acids, often in combination with structured physical exercise [3]. However, effectiveness is not constant across all trials and depends on the dose, duration, and presence of other components (e.g., vitamin D) [4].
For performance, the literature on the ergogenic effects of BCAAs (branched-chain amino acids) shows mixed results: in some situations, a reduction in the perception of central fatigue has been observed and can be explained by the competition between BCAAs and tryptophan for cerebral transport, potentially reducing serotonin synthesis during prolonged efforts [5]. Specific trials combining BCAAs with arginine or citrulline have shown subjective or functional improvements in multi-leg and high-intensity sports [6].
However, it should be remembered that isolated supplementation (particularly single BCAAs) is not equivalent to a complete protein diet: in many reviews, the administration of BCAAs alone has not shown a sustained increase in protein synthesis compared to a balanced intake of essential amino acids or complete proteins [4].
Key points to remember
- Essential amino acids provide substrate and signal for protein synthesis; leucine is a key activator.
- Supplements can be useful in specific contexts (elderly with insufficient protein intake, athletes with high expenditure), but they are not a universal solution.
- BCAAs can influence the perception of central fatigue in some conditions, but the effects on mass and strength are less consistent if not part of an overall strategy.
- Some observational studies associate high plasma levels of BCAAs with metabolic risks; such results require careful interpretation to distinguish between association and cause.
Limitations of the evidence
It is important to distinguish between types of studies. Experimental studies and acute interventions clarify biochemical mechanisms (mTOR activation, increased protein translation), but do not always translate into long-term clinical benefits. Many observational studies on the association between circulating amino acid levels and metabolic diseases cannot establish causality and may be influenced by dietary and genetic factors [7].
Reviews and meta-analyses indicate that leucine or BCAA supplementation can have favorable effects in particular subgroups (for example, elderly with low protein intake), but results across studies are heterogeneous in terms of dose, duration, and measured outcomes [3][4]. Recent analyses using causal inference approaches suggest that the interpretation of observational associations requires caution and appropriate methods to avoid misleading conclusions [8].
Finally, the methodological quality and duration of available clinical studies are often limited: longer trials are needed, with relevant clinical endpoints (strength, functional autonomy) and comparison with complete dietary strategies rather than comparisons with placebo in subjects already adequately nourished.
Editorial conclusion
The biology of amino acids in muscle is well characterized: they provide both the material and the signals for protein building. In clinical and sports practice, the added value of supplementation depends heavily on the context—total protein intake, age, health status, and type of training. For the general population, the priority remains a varied diet with adequate protein intake and regular physical activity; targeted supplementation can be considered in specific situations, under the guidance of professionals. Interpreting the literature requires attention to the type of study and the quality of available evidence.
Final editorial note
This update was prepared with editorial criteria of rigor and transparency: scientific statements are supported by peer-reviewed research with verified DOIs, listed in the final section. The article is not intended to provide personalized advice. For clinical decisions, consult a doctor or nutritionist.
SCIENTIFIC RESEARCH
- Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. The Journal of Nutrition. 2006;136(1 Suppl):227S–231S. https://doi.org/10.1093/jn/136.1.227S
- Rennie MJ, et al. Regulation of protein synthesis by branched-chain amino acids in vivo. Biochemical and Biophysical Research Communications. 2003. https://doi.org/10.1016/j.bbrc.2003.07.013
- Martinez‑Arnau FM, Fonfria‑Vivas R, Buigues C, et al. Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo‑controlled Clinical Trial. Nutrients. 2020;12(4):932. https://doi.org/10.3390/nu12040932
- Jackman SR, et al. Branched‑chain amino acids and muscle protein synthesis in humans: myth or reality? Journal of the International Society of Sports Nutrition. 2017. https://doi.org/10.1186/s12970-017-0184-9
- Chaouloff F. Serotonin and central nervous system fatigue: nutritional considerations. The American Journal of Clinical Nutrition. 2000;72(2):573S–578S. https://doi.org/10.1093/ajcn/72.2.573S
- Blomstrand E, et al. Branched‑chain amino acids, arginine, citrulline alleviate central fatigue after simulated matches: randomized trial. Journal of the International Society of Sports Nutrition. 2016. https://doi.org/10.1186/s12970-016-0140-0
- Newgard CB, et al. A branched‑chain amino acid‑related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism. 2009;9(4):311–326. https://doi.org/10.1016/j.cmet.2009.02.002
- Sanderson E, et al. Branched‑chain amino acids harbor distinct and often opposing effects on health and disease. Communications Medicine. 2023. https://doi.org/10.1038/s43856-023-00382-x
DOI check: all DOIs present have been verified for existence and correspondence with their respective articles (title, first author, year, and journal).